Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

NCT03326674 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

685

Enrollment

INDUSTRY

Sponsor class

Stopped The Sponsor has discontinued the development of tesetaxel

Conditions

Breast Cancer

Interventions

DRUG: Tesetaxel and Capecitabine
DRUG: Capecitabine

Sponsor

Odonate Therapeutics, Inc.